Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lipovsek

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Protein Engineering, Design & Selection : PEDS|November 12, 2010
Adnectins: engineered target-binding protein therapeuticsD Lipovsek
Nature Biotechnology|March 30, 1999
Smartbombs and cloaking devicesR W Wagner, D Lipovsek
Antiviral Research|December 24, 1998
Hepatitis C virus NS3/4A proteaseA D Kwong, J L Kim, G Rao, et al.
Antiviral Research|May 13, 1999
Hepatitis C virus NS3/4A proteaseA D Kwong, J L Kim, G Rao, et al.
Protein Engineering, Design & Selection : PEDS|March 16, 2011
Secretion-and-capture cell-surface display for selection of target-binding proteinsJ A Rakestraw, D Aird, P M Aha, et al.
Protein Engineering, Design & Selection : PEDS|August 10, 2005
Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor twoM H Parker, Y Chen, F Danehy, et al.
Infection and Immunity|October 1, 1987
Genes for immunodominant protein antigens are highly homologous in Mycobacterium tuberculosis, Mycobacterium africanum, and the vaccine strain Mycobacterium bovis BCGM C Lu, M H Lien, R E Becker, et al.
Nature Communications|November 9, 2018
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancerA N Niemeijer, D Leung, M C Huisman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Protein Engineering, Design & Selection : PEDS|November 12, 2010
Adnectins: engineered target-binding protein therapeuticsD Lipovsek
Nature Biotechnology|March 30, 1999
Smartbombs and cloaking devicesR W Wagner, D Lipovsek
Antiviral Research|December 24, 1998
Hepatitis C virus NS3/4A proteaseA D Kwong, J L Kim, G Rao, et al.
Antiviral Research|May 13, 1999
Hepatitis C virus NS3/4A proteaseA D Kwong, J L Kim, G Rao, et al.
Protein Engineering, Design & Selection : PEDS|March 16, 2011
Secretion-and-capture cell-surface display for selection of target-binding proteinsJ A Rakestraw, D Aird, P M Aha, et al.
Protein Engineering, Design & Selection : PEDS|August 10, 2005
Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor twoM H Parker, Y Chen, F Danehy, et al.
Infection and Immunity|October 1, 1987
Genes for immunodominant protein antigens are highly homologous in Mycobacterium tuberculosis, Mycobacterium africanum, and the vaccine strain Mycobacterium bovis BCGM C Lu, M H Lien, R E Becker, et al.
Nature Communications|November 9, 2018
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancerA N Niemeijer, D Leung, M C Huisman, et al.
Pageof 1